Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Ono's elastase inhibitor poised to enter phase I in Europe

Nov. 27, 1997

Fujirebio, Nippon Chemiphar to codevelop antiasthma drug

Nov. 26, 1997

Arzneimittelwerk Dresden prepares new 5-LO inhibitors

Nov. 26, 1997

Dual CysLT1/H1 receptor antagonists described in patent literature

Nov. 25, 1997

New NK1 antagonist from Novartis

Nov. 24, 1997

Accolate now available in Canada

Nov. 21, 1997

RPR redirects development of PDE IV inhibitor

Nov. 21, 1997

New NK3/NK4 antagonist in the pipeline at SKB

Nov. 20, 1997

Extensive preclinical results described for new NK2 antagonist

Nov. 20, 1997

Beclometasone CFC-free MDI for chronic bronchial asthma approved

Nov. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...